Gut Microbes

Article	Citations
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	220
Effect of diet on the evolution of gut commensal bacteria	193
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	188
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	184
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	146
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	145
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	132
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	106
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	105
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	100
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	95
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	89
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	88
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	87
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	84
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	82
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	78
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	77
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	76
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	74
Modeling spatial interaction networks of the gut microbiota	74
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	73
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	70
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	70
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	70

Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	69
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	67
Intestinal bacteria and colorectal cancer: etiology and treatment	67
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	65
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	65
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	65
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	65
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	64
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	64
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	64
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	63
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	62
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	60
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	60
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	58
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	57
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	56
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	56
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	56
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	55
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	55
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	55
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	55
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	55
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	54
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	53
Akkermansia in the gastrointestinal tract as a modifier of human health	53
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	52
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	52
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	52
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	52
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	52
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	51
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	51
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	51
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection	50
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	50
Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design	49
Role of gut microbes in acute lung injury/acute respiratory distress syndrome	49
Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies	49
The multifaceted virulence of adherent-invasive Escherichia coli	49
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content	49
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	49
Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan	48
Integrative analysis with microbial modelling and machine learning uncovers potential alleviators for ulcerative colitis	47
CobB-mediated deacetylation of the chaperone CesA regulates Escherichia coli O157:H7 virulence	47
Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway	46
Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis	46
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?	46
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	46

The transplantation of the gut microbiome of fat-1 mice protects against colonic mucus layer disruption and endoplasmic reticulum stress induced by high fat diet	45
Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy	45
Entamoeba muris mitigates metabolic consequences of high-fat diet in mice	45
Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward	44
Intestinal deguelin drives resistance to acetaminophen-induced hepatotoxicity in female mice	44
Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “Gut-Immune-Bone” axis	44
CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA	43
Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide	43
Comprehensive assessment of machine learning methods for diagnosing gastrointestinal diseases through whole metagenome sequencing data	43
Alterations in mucosa branched N -glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation	43
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights	42
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion	42
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain	42
Why are so many enteric pathogen infections asymptomatic? Pathogen and gut microbiome characteristics associated with diarrhea symptoms and carriage of diarrheagenic E. coli	41
The human gut microbiome and aging	40
Quorum sensing modulates bacterial virulence and colonization dynamics of the gastrointestinal pathogen Citrobacter rodentium	40
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bi	40
Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus -associated host cognitive impairment	40
From a hunger-regulating hormone to an antimicrobial peptide: gastrointestinal derived circulating endocrine hormone-peptide YY exerts exocrine antimicrobial effects against selective gut microbiota	39
Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella -induced arthritis	39
Enterohemorrhagic Escherichia coli responds to gut microbiota metabolites by altering metabolism and activating stress responses	39
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis	39
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals	39
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease	39
Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavioral and neuroendocrine changes in a nonhuman primate model	39
Salmonella utilizes L-arabinose to silence virulence gene expression for accelerated pathogen growth within the host	38
Membrane protective role of autophagic machinery during infection of epithelial cells by Candida albicans	38
Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model	38
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohort	38
Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor	38
Lactic acid bacteria and bifidobacteria deliberately introduced into the agro-food chain do not significantly increase the antimicrobial resistance gene pool	38
Fusobacterium nucleatum -driven CX3CR1 + PD-L1 + phagocytes route to tumor tissues and reshape tumor microenvir	37
The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC	37
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms	37
PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression	37
Microbiome’s role in musculoskeletal health through the gut-bone axis insights	37
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celi	36
Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria	36
Human milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms	36
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	36
Gut microbiome at the crossroad of genetic variants and behavior disorders	36
Infant gut microbiota restoration: state of the art	36
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma	36
PUFAs add fuel to Crohn’s disease-associated AIEC-induced enteritis by exacerbating intestinal epithelial lipid peroxidation	36
Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota	36
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease	35
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use	35
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	34
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma	34
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data	34
Exploring substrate–microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions	34
Magnetic chitin beads (MCB) coated with Vibrio cholerae reveals transcriptome dynamics in adult mice with a complex gut microbiota	33
Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection	33
Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn’s disease	33
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes	33
Akkermansia muciniphila : a deworming partner independent of type 2 immunity	33
High variation across E. coli hybrid isolates identified in metabolism-related biological pathways co-expressed with virulent genes	33
Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis	33
Mouse strain-specific responses along the gut-brain axis upon fecal microbiota transplantation from children with autism	32
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease	32
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion	32
Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis	32
The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk	32
Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD	32
Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa	32
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity	31
Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes	31
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis	31
Integrated analysis of gut metabolome, microbiome, and brain function reveal the role of gut-brain axis in longevity	31
Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites	31
IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation	31
Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis	30
Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model mice	30
ZntA maintains zinc and cadmium homeostasis and promotes oxidative stress resistance and virulence in Vibrio parahaemolyticus	30
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response	30
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases	30
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics	30
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats	30
Using a human colonoid-derived monolayer to study bacteriophage translocation	30
Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice	30

The interplay between PCOS pathology and diet on gut microbiota in a mouse model	30
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease	29
A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model	29
Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics	29
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	29
Alcaligenes faecalis promotes colitis to colorectal cancer transition through IgA+ B cell suppression and vinculin acetylation	29
Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota	29
Maternal-infant probiotic transmission mitigates early-life stress-induced autism in mice	29
Actively replicating gut bacteria identified by 5-ethynyl-2’-deoxyuridine (EdU) click chemistry and cell sorting	29
Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis	29
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention	29
Neonatal necrotizing enterocolitis: Clostridium butyricum and Clostridium neonatale fermentation metabolism and enteropathogenicity	29
Diet-induced shifts in the gut microbiota influence anastomotic healing in a murine model of colonic surgery	29
M28 family peptidase derived from Peribacillus frigoritolerans initiates trained immunity to prevent MRSA via the complosome-phosphatidylcholine axis	29
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation	29
Fabry disease – a multisystemic disease with gastrointestinal manifestations	29
Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a post-hoc analysis of a randomized clinical trial	29
Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection	28
Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation	28
Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces	28
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies	28
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial	28
Dietary S. maltophilia induces supersized lipid droplets by enhancing lipogenesis and ER-LD contacts in C. elegans	28
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis	28
Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis	28
Diet standardization reduces intra-individual microbiome variation	28
Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway	28
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes	27
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project	27
Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction	27
Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair	27
Primers matter: Influence of the primer selection on human fungal detection using high throughput sequencing	27
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions	27
The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging	27
Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin	27
The hidden base of the iceberg: gut peptidoglycome dynamics is foundational to its influence on the host	27
The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia	27
Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic	27
Fucose promotes intestinal stem cell-mediated intestinal epithelial development through promoting Akkermansia -related propanoate metabolism	27
DSS treatment does not affect murine colonic microbiota in absence of the host	27
Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis	26
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health	26
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice	26
Gut microbiome in healthy aging versus those associated with frailty	26
Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation	26
Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles	25
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications	25
The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging – relevant neural and immune function	25
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure	25
Better together– Salmonella biofilm-associated antibiotic resistance	25
Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response	24
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota	24
Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats	24
Psyllium fiber protects mice against western diet-induced metabolic syndrome via the gut microbiota-dependent mechanism	24
Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice	24
Preterm infants at low risk for early-onset sepsis differ in early fecal microbiome assembly	24
Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation	23
Bifidobacterium inhibits the progression of colorectal tumorigenesis in mice through fatty acid isomerization and gut microbiota modulation	23
Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomye	23
Muropeptides and muropeptide transporters impact on host immune response	23
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus	23
Methodological challenges in neonatal microbiome research	23
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma	23
Abnormalities in gut virome signatures linked with cognitive impairment in older adults	23
How longitudinal data can contribute to our understanding of host genetic effects on the gut microbiome	23
Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury	23
Genetic variation in gut microbe as a key regulator of host social behavior in C. elegans	22
The effects of gut microbiota on appetite regulation and the underlying mechanisms	22
Metagenomic source tracking after microbiota transplant therapy	22
Hydrogen peroxide in breast milk is crucial for gut microbiota formation and myelin development in neonatal mice	22
The early life exposome and autism risk: a role for the maternal microbiome?	22
Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions	22
Effects of Prevotella copri on insulin, gut microbiota and bile acids	22
New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation	21
Mucus, commensals, and the immune system	21
Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation	21
Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells	21
The influence of the gut microbiome on ovarian aging	21
Parity modulates impact of BMI and gestational weight gain on gut microbiota in human pregnancy	21
The human gut serves as a reservoir of hypervirulent Klebsiella pneumoniae	21
Correction	21
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes	21
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients	21
Gut microbiota-derived butyrate selectively interferes with growth of carbapenem-resistant Escherichia coli based on their resistance mechanism	20
The role of the early-life gut microbiome in childhood asthma	20
Segmental patterning of microbiota and immune cells in the murine intestinal tract	20
mNFE: microbiome network flow entropy for detecting pre-disease states of type 1 diabetes	20
Chemotherapy-induced microbiota exacerbates the toxicity of chemotherapy through the suppression of interleukin-10 from macrophages	20
The cnf1 gene is associated with an expanding Escherichia coli ST131 H 30Rx/C2 subclade and confers a compe	20
Transcriptional profiling of zebrafish intestines identifies macrophages as host cells for human norovirus infection	20
Segmented filamentous bacteria impede rotavirus infection via retinoic acid receptor-mediated signaling	20
Linkage analysis identifies novel genetic modifiers of microbiome traits in families with inflammatory bowel disease	20
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?	20
Translating neonatal microbiome science into commercial innovation: metabolism of human milk oligosaccharides as a basis for probiotic efficacy in breast-fed infants	20
A history of repeated antibiotic usage leads to microbiota-dependent mucus defects	20